ANAB vs. APH
ANAB (AnaptysBio, Inc.) and APH (Amphenol Corporation) are both stocks. ANAB operates in Biotechnology (Healthcare), while APH operates in Electronic Components (Technology). Over the past 5 years, ANAB returned 27.51%/yr vs 34.98%/yr for APH. At a 0.22 correlation, their price movements are largely independent.
Performance
ANAB vs. APH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANAB achieves a 58.54% return, which is significantly higher than APH's 9.45% return.
ANAB
- 1D
- -0.04%
- 1M
- -26.57%
- YTD
- 58.54%
- 6M
- 75.64%
- 1Y
- 226.79%
- 3Y*
- 60.13%
- 5Y*
- 27.51%
- 10Y*
- —
APH
- 1D
- -0.53%
- 1M
- 4.67%
- YTD
- 9.45%
- 6M
- 6.89%
- 1Y
- 62.16%
- 3Y*
- 57.45%
- 5Y*
- 34.98%
- 10Y*
- 27.09%
ANAB vs. APH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANAB AnaptysBio, Inc. | 58.54% | 266.16% | -38.19% | -30.88% | -10.82% | 61.63% | 32.31% | -74.53% | -36.67% | 492.47% |
APH Amphenol Corporation | 9.45% | 96.08% | 41.30% | 31.85% | -11.96% | 35.25% | 22.09% | 34.91% | -6.82% | 32.92% |
Correlation
The correlation between ANAB and APH is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 27, 2017 | 0.22 |
The correlation between ANAB and APH shifts across timeframes, from 0.07 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ANAB:
$1.47B
APH:
$190.39B
ANAB:
-$0.91
APH:
$4.58
ANAB:
6.50
APH:
7.31
ANAB:
115.33
APH:
13.62
ANAB:
$232.39M
APH:
$25.90B
ANAB:
$245.59M
APH:
$9.67B
ANAB:
$52.72M
APH:
$7.45B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANAB vs. APH — Risk / Return Rank
ANAB
APH
ANAB vs. APH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AnaptysBio, Inc. (ANAB) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ANAB | APH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.70 | ||
| Sortino ratioReturn per unit of downside risk | +1.66 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.28 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 8.11 | 2.22 | +5.90 |
| Martin ratioReturn relative to average drawdown | 20.93 | 5.79 | +15.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ANAB | APH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.24 | 1.55 | +1.70 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 1.16 | -0.73 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.98 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.63 | -0.40 |
Drawdowns
ANAB vs. APH - Drawdown Comparison
The maximum ANAB drawdown since its inception was -92.08%, which is greater than APH's maximum drawdown of -63.41%. Use the drawdown chart below to compare losses from any high point for ANAB and APH.
Loading charts...
Drawdown Indicators
| ANAB | APH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.08% | -63.41% | -28.67% |
Max Drawdown (1Y)Largest decline over 1 year | -28.15% | -28.19% | +0.04% |
Max Drawdown (3Y)Largest decline over 3 years | -69.32% | -28.19% | -41.13% |
Max Drawdown (5Y)Largest decline over 5 years | -69.32% | -28.73% | -40.59% |
Max Drawdown (10Y)Largest decline over 10 years | — | -37.56% | — |
Current DrawdownCurrent decline from peak | -40.21% | -11.03% | -29.18% |
Average DrawdownAverage peak-to-trough decline | -64.74% | -13.56% | -51.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.92% | 10.76% | +0.16% |
Volatility
ANAB vs. APH - Volatility Comparison
The current volatility for AnaptysBio, Inc. (ANAB) is 11.47%, while Amphenol Corporation (APH) has a volatility of 15.91%. This indicates that ANAB experiences smaller price fluctuations and is considered to be less risky than APH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANAB | APH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.47% | 15.91% | -4.44% |
Volatility (6M)Calculated over the trailing 6-month period | 46.57% | 36.03% | +10.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.75% | 40.39% | +30.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.34% | 30.42% | +34.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.51% | 27.75% | +47.76% |
Dividends
ANAB vs. APH - Dividend Comparison
ANAB has not paid dividends to shareholders, while APH's dividend yield for the trailing twelve months is around 0.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANAB AnaptysBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
APH Amphenol Corporation | 0.56% | 0.55% | 0.79% | 1.07% | 1.06% | 0.89% | 0.80% | 0.89% | 1.09% | 0.80% | 0.86% | 1.01% |
Financials
ANAB vs. APH - Financials Comparison
This section allows you to compare key financial metrics between AnaptysBio, Inc. and Amphenol Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ANAB and APH have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
APH has higher volatility (15.91%) compared to ANAB (11.47%). In terms of maximum drawdown, ANAB dropped -92.08% vs APH's -63.41%.
ANAB currently has the higher Sharpe Ratio (3.24 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANAB and APH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer